Results 11 to 20 of about 3,005,072 (284)

Development of a predictive machine learning model for pathogen profiles in patients with secondary immunodeficiency [PDF]

BMC Medical Informatics and Decision Making
Background Secondary immunodeficiency can arise from various clinical conditions that include HIV infection, chronic diseases, malignancy and long-term use of immunosuppressives, which makes the suffering patients susceptible to all types of pathogenic ...
Qianning Liu, Yifan Chen, Peng Xie, Ying Luo, Buxuan Wang, Yuanxi Meng, Jiaqian Zhong, Jiaqi Mei, Wei Zou   +8 more
doaj   +3 more sources

Immunization of children with secondary immunodeficiency [PDF]

Human Vaccines & Immunotherapeutics, 2015
The main causes of secondary immunodeficiency at a pediatric age include infectious diseases (mainly HIV infection), malignancies, haematopoietic stem cell or solid organ transplantation and autoimmune diseases. Children with secondary immunodeficiency have an increased risk of severe infectious diseases that could be prevented by adequate vaccination ...
Esposito, Susanna Maria Roberta, E. Prada, M. Lelii, L. Castellazzi   +3 more
openaire   +4 more sources

Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East

Frontiers in Hematology
Secondary immunodeficiency (SID), acquired hypogammaglobinemia, is an immunodeficiency caused by different factors like diseases, medications, and/or nutrition disorders.
Maria Dimou, Mohamed Abuzakouk, Mona Al Ahmad, Khalil Al Farsi, Ahmad Alhuraiji, Fayhan Al Roqi, Fayhan Al Roqi, Fayhan Al Roqi, Ahmed Alsaeed, Ahmed Alsaeed, Ahmed Alsaeed, Mohsen Alzahrani, Mohsen Alzahrani, Mohsen Alzahrani, Ali Bazarbachi, Honar Cherif, Riad El Fakih, Carla Irani, Faraz Khan, Iman Nasr, Hani Yousif Osman, Mustaqeem Siddiqui   +21 more
doaj   +3 more sources

Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations [PDF]

Journal of Clinical Medicine, 2023
Sánchez-Ramón Silvia, Concha Boqué, Raúl Córdoba   +2 more
exaly   +2 more sources

Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis [PDF]

Cancers, 2023
Maria Dimou, Dorte Huscher, David Pittrow   +2 more
exaly   +2 more sources

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience [PDF]

Journal of Allergy and Clinical Immunology, 2021
Adrian Shields, Siniša Savic, Siobhan Burns   +2 more
exaly   +2 more sources

Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab

Hematology, 2022
Objectives: Chemotherapy, including bendamustine, usually causes lymphocytopaenia and hypogammaglobulinaemia as side effects in patients with haematological malignancies.
Akie Hirata, Kaname Miyashita, Takafumi Tanaka, Kiyoko Hirata, Taisuke Narazaki, Hayato Utsunomiya, Hirofumi Ohno, Eriko Nakashima, Yoshimichi Tachikawa, Ilseung Choi, Kenichi Taguchi, Youko Suehiro   +11 more
doaj   +1 more source

Interstitial Lung Disease in Immunocompromised Children

Diagnostics, 2022
Background: The range of pulmonary complications beyond infections in pediatric immunocompromised patients is broad but not well characterized. Our goal was to assess the spectrum of disorders with a focus on interstitial lung diseases (ILD) in ...
Xianfei Gao, Katarzyna Michel, Matthias Griese   +2 more
doaj   +1 more source

Evaluation of the effectiveness of the proposed therapy on energy metabolism parameters in patients with chronic liver lesions on the background of secondary immunodeficiency state

Медицинский вестник Юга России, 2023
Objective: to study the effect of a combination of azoximer bromide (AB) and human placenta hydrolysate (HPН) on metabolic processes in patients with chronic liver lesions on the background of secondary immunodeficiency.
M. Yu. Perfilyeva, Y. A. Sotskaya
doaj   +1 more source

Secondary immunodeficiency (immunocompromised patient). Lecture

Zdorovʹe Rebenka, 2020
The lecture summarizes modern world data on the determination of secondary immunodeficiency (SID), approaches to diagnosis and treatment. The main immunocompromising factors are listed.
L.I. Chernyshova
doaj   +1 more source